During the past decade, Denver Heart conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Denver Heart" are "Heart Failure" (3 trials), "Patent Foramen Ovale" (1 trials), "Peripheral Arterial Occlusive Disease" (1 trials), "Stroke" (1 trials) and "Ventricular Tachycardia" (1 trials). Many other conditions were trialed in "Denver Heart" in a lesser frequency.

Most popular intervention types in "Denver Heart" are "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AMPLATZER™ PFO Occluder" (1 trials), "Cardiac Resynchronization Therapy - MPP" (1 trials), "Intrinsic Antitachycardia Pacing (iATP) Therapy" (1 trials), "Observational" (1 trials) and "PAD endovascular treatments" (1 trials). Other intervention names were less common.

The vast majority of trials in "Denver Heart" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Denver Heart". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Denver Heart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Denver Heart, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".